Tumor stromal prognostic value was independent of ER or HER2 expression, grade, age, chemo- or endocrine-therapy [80], highlighting the importance of stromal biology in tumor progression and patient clinical outcome. This evidence concerns the gene ERBB2 and neoplasm.